CTNM Contineum Therapeutics, Inc.

NASDAQ

$7.90

Contineum Therapeutics, Inc. (CTNM) Earnings News

Earnings press releases, previews and reviews for Contineum Therapeutics, Inc. (CTNM), newest first.

Thursday July 30, 2026 4:05 PM ET

Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones

Tuesday May 5, 2026 4:05 PM ET

Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones